Group 1 - The company held its seventh supervisory board's fifth meeting on August 20, 2025, which was conducted via telecommunication and was attended by all supervisory members and executives [2][4]. - The supervisory board unanimously agreed to reduce the investment scale of certain fundraising projects, conclude some fundraising projects, and permanently supplement the remaining raised funds into working capital [3][4]. - The decision to reduce the investment scale and conclude projects is based on the company's current situation and aims to improve the efficiency of fund usage and lower financial costs, benefiting the company and all shareholders, particularly minority shareholders [2][3]. Group 2 - The meeting was legally valid and complied with the Company Law of the People's Republic of China and the company's articles of association [2]. - The company will publish detailed information regarding the reduction of fundraising investment scale and the conclusion of projects in major financial newspapers and platforms [3][4].

Meeting Information - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 9, 2025, at 15:00 [2] - Network voting will be available on the same day from 9:15 to 15:00 through the Shenzhen Stock Exchange trading system and internet voting system [2][3] Voting Procedures - Shareholders can choose between on-site voting and network voting, with the first vote counted in case of duplicate votes [3] - All ordinary shareholders registered by the close of business on September 3, 2025, are eligible to attend and vote [3][4] Agenda Items - The meeting will review a proposal to reduce the scale of certain fundraising investments, conclude fundraising projects, and permanently supplement working capital with surplus funds [3][4] - The proposal has already been approved by the company's board and supervisory committee [3] Registration and Participation - Natural persons must present valid identification and shareholding certificates for registration [6] - Legal entities must provide a copy of the business license, shareholding certificates, and authorization letters for their representatives [6] - Remote shareholders can register via mail, fax, or letter [6] Voting Process - The voting will be a non-cumulative voting process, allowing shareholders to express their opinions as agree, disagree, or abstain [7] - Specific procedures for voting through the Shenzhen Stock Exchange systems are outlined in the meeting documents [7]

Core Viewpoint - A drying equipment explosion occurred at Rhine Biotech on August 21, 2025, resulting in one death and multiple injuries, with ongoing investigations into the cause of the incident [1] Incident Summary - The explosion took place in a drying workshop, leading to one fatality, three serious injuries, and four minor injuries [1] - The company is cooperating with government authorities for the treatment of the injured and the investigation of the incident [1] Financial Impact - Preliminary estimates indicate property damage of approximately 2 million yuan due to the explosion [1] - The incident is not expected to have a significant adverse impact on the company's future production and operations [1] Production Process - The company's plant extraction process includes several stages: pretreatment, extraction, separation, purification, concentration, drying, and packaging [1]

Core Viewpoint - A drying equipment explosion occurred at Rhine Biotech on August 21, 2025, resulting in one death and multiple injuries, with ongoing investigations into the cause [1] Incident Summary - The explosion took place in a drying workshop at 5:40 AM, leading to 1 fatality, 3 serious injuries, and 4 minor injuries [1] - The company is cooperating with government authorities for the treatment of the injured and the investigation of the incident [1] Financial Impact - Preliminary estimates indicate property damage of approximately 2 million yuan due to the explosion [1] - The incident is not expected to have a significant adverse impact on the company's future operations [1] Production Process - The company's production process includes several stages: pretreatment, extraction, separation, purification, concentration, drying, and packaging [1] - The explosion occurred in one of the drying workshops, affecting that specific area and its equipment [1]

Core Viewpoint - The explosion at a drying facility of Rhine Biotech (002166.SZ) resulted in one fatality and multiple injuries, but the company asserts that it will not significantly impact future operations [1] Incident Summary - On August 21, 2025, an explosion occurred at a drying equipment in one of the company's facilities, leading to one death, three serious injuries, and four minor injuries [1] - The preliminary assessment indicates property damage of approximately 2 million yuan [1] Company Response - The company plans to conduct a comprehensive safety inspection and implement measures to prevent future incidents [1]

Core Viewpoint - A drying equipment explosion occurred at a company's facility on August 21, 2025, resulting in one fatality and multiple injuries, while the company is actively cooperating with government authorities for emergency response and investigation [1] Incident Summary - The explosion took place in a drying workshop, leading to one death, three serious injuries, and four minor injuries [1] - The company has initiated an emergency response plan and formed a leadership group to manage the situation and assist in rescue efforts [1] - The specific cause of the accident is currently under investigation, with the company fully cooperating with relevant government departments [1] Financial Impact - Preliminary estimates indicate property damage of approximately 2 million yuan due to the incident [1] - The company asserts that this accident will not have a significant adverse impact on its future production and operations [1] Production Process - The company's plant extraction production process includes several stages: pretreatment, extraction, separation, purification, concentration, drying, and packaging [1] - The incident occurred in one of the drying workshops, affecting the assets related to that specific area [1]

光大证券股份有限公司 关于桂林莱茵生物科技股份有限公司缩减部分募集资金投资 规模、结项募投项目并将节余募集资金永久补充流动资金的 核查意见 光大证券股份有限公司（以下简称"光大证券"或"保荐机构"）作为桂林莱 茵生物科技股份有限公司（以下简称"莱茵生物"或"公司"）2020年非公开发行 股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第13号——保荐业务》《上 市公司募集资金监管规则》等有关规定，对莱茵生物缩减部分募集资金投资规模、 结项募投项目并将节余募集资金永久补充流动资金事项进行了核查，核查情况及意 见如下： 经中国证券监督管理委员会证监许可[2021]2843号文《关于核准桂林莱茵生物 科技股份有限公司非公开发行股票的批复》核准，并经深圳证券交易所同意，公司 非公开发行股票在深圳证券交易所上市交易。本次非公开发行人民币普通股（A股） 165,470,085股，发行价为每股人民币5.85元，本次发行共募集资金967,999,997.25元， 扣除各项不含税发行费用6,890,066.13元后，募集资金净额为961,109,931 ...

桂林莱茵生物科技股份有限公司 证券代码：002166 证券简称：莱茵生物 公告编号：2025-047 桂林莱茵生物科技股份有限公司 关于公司发生安全事故的公告 二、本次事故预计对公司可能产生的影响 公司植物提取的生产工序分为前处理、提取、分离、纯化、浓缩、干燥及包 装等。本次事故发生在其中一个干燥车间，对该车间、设备等资产造成一定的损 失，初步核算财产损失约 200 多万元。本次事故不会对公司未来生产经营造成重 大不利影响。 为深刻吸取此次事故教训，进一步加强安全生产管理，公司将全面深入开展 安全生产自查工作，落实事故防范和整改措施，进一步消除可能存在的安全隐患。 公司将根据本次事故的进展，及时按照相关规定履行信息披露义务，敬请广 大投资者注意投资风险。 公司对本次事故中罹难的员工表示沉痛哀悼！对受伤员工及其家属、罹难员 工家属表示深切慰问，对给员工及其家庭造成的伤害深表歉意。 特此公告。 桂林莱茵生物科技股份有限公司董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本次事故的具体情况 2025 年 8 月 21 日 5 时 40 分许，桂林莱茵生物 ...

桂林莱茵生物科技股份有限公司 证券代码：002166 证券简称：莱茵生物 公告编号：2025-044 桂林莱茵生物科技股份有限公司 关于缩减部分募集资金投资规模、结项募投项目并将节余募集资金 永久补充流动资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、公司结项募集资金投资项目名称："甜叶菊专业提取工厂建设项目"；缩 减募集资金投资规模并结项项目名称："莱茵天然健康产品研究院建设项目"。 2、上述项目结项后进行永久补充流动资金的募集资金共计：31,534.00 万元， 其中，募集资金实际节余金额为 15,853.02 万元，预估待支付募投项目尾款金额 为 15,680.98 万元（最终数据以资金转出当日银行结息余额为准）。 3、本事项尚需提交公司股东会审议。 桂林莱茵生物科技股份有限公司（以下简称"公司"、"莱茵生物"）于 2025 年 8 月 20 日召开了第七届董事会第六次会议和第七届监事会第五次会议， 审议通过了《关于缩减部分募集资金投资规模、结项募投项目并将节余募集资金 永久补充流动资金的议案》，同意公司缩减部分募集资金投 ...

桂林莱茵生物科技股份有限公司 证券代码：002166 证券简称：莱茵生物 公告编号：2025-045 桂林莱茵生物科技股份有限公司 关于 2025 年度开展融资租赁售后回租业务的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2025 年 8 月 20 日，桂林莱茵生物科技股份有限公司（以下简称"公司"） 第七届董事会第六次会议审议通过了《关于 2025 年度开展融资租赁售后回租业 务的议案》，现将具体情况公告如下： 一、融资租赁售后回租业务概述 为拓宽融资渠道，优化公司融资结构，满足公司经营及业务发展资金需求， 公司及合并报表范围内子公司（含授权期限内新设立或纳入合并范围的子公司） 拟与具有相应资质的融资租赁机构开展融资租赁售后回租业务，融资总金额不超 过 30,000 万元，融资额度的有效期自公司董事会审批通过之日起 12 个月内有效。 同时，为提高决策效率，确保该业务高效实施，公司董事会授权公司管理层在批 准的额度内办理公司及子公司融资租赁售后回租业务相关事宜。 上述事项已经公司第七届董事会第六次会议审议通过，无需提交股东会审议。 本次交易不构成关 ...